Skip to main content
FinSpry Logo
FinSpry
GENB logo
GENB
(NASDAQ)
Generate Biomedicines, Inc.
$13.90-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Generate Biomedicines (GENB) Stock Price & Financial Analysis

Generate Biomedicines Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$13.85 - $14.40
52-Week High$18.18
52-Week Low$11.00
Open$14.22
Volume269.32K
Average Volume (3M)919.88K
Market Cap1.84B
Shares Outstanding128.19M
Price to Sales (P/S)54.91
Price to Book (P/B)3.40
EV/EBITDA-7.94
Revenue (TTM)31.89M
Net Income (TTM)-203.15M
Free Cash Flow (TTM)-204.13M
EPS (TTM)$-6.16
Profit Margin-636.99%
Operating Margin-737.04%
Return on Equity (ROE)-39.46%
Debt to Equity0.13
50-Day MA$14.44
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Generate Biomedicines

What is the current stock price for GENB?

As of the latest trading session, GENB stock trades at $13.90. The 52-week range is $11.00–$18.18, with a day range of $13.85–$14.40.

What is the P/E ratio for GENB?

The P/E ratio (Price-to-Earnings) for GENB is shown in the Key Statistics section. This valuation metric helps compare Generate Biomedicines, Inc. to industry peers.

Does GENB pay dividends?

Generate Biomedicines does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for GENB?

Based on 5 analysts, the consensus for GENB is Buy.

What is the market cap of GENB?

Generate Biomedicines's market capitalization is $1.78B, classifying it as a small-cap company. Generate Biomedicines operates in the Healthcare sector within the Biotechnology industry.